[Bisphosphonates and combined treatments osteoporosis]
[Article in
French]
Affiliations
- PMID: 16268449
Item in Clipboard
[Bisphosphonates and combined treatments osteoporosis]
[Article in
French]
Rev Med Suisse.
.
Abstract
Bisphosphonates are inhibitors of bone resorption, which reduce vertebral and non-vertebral fracture risk. Their efficacity has been shown in controlled trials up to 5 years, and their safety up to ten years. There is no proven benefit of combining two bone resorption inhibitors.
Similar articles
-
Issues in designing and testing a "cure" for osteoporosis.J Musculoskelet Neuronal Interact. 2004 Dec;4(4):408. J Musculoskelet Neuronal Interact. 2004. PMID: 15758283 Review. No abstract available.
-
[Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate].Clin Calcium. 2007 Jan;17(1):18-22. Clin Calcium. 2007. PMID: 17211089 Review. Japanese.
-
Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies.Curr Med Res Opin. 2009 Aug;25(8):1861-8. doi: 10.1185/03007990903035281. Curr Med Res Opin. 2009. PMID: 19530978
-
[New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].Clin Calcium. 2009 Jan;19(1):44-53. Clin Calcium. 2009. PMID: 19122264 Review. Japanese.
-
[Anabolic treatment for osteoporosis: PTH treatment].Clin Calcium. 2006 Sep;16(9):1480-85. Clin Calcium. 2006. PMID: 16951472 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical